Faisal Laljee

Insmed's Stock Already Has Worst Case Scenario Priced In (INSM)

Did you not see what happened to VLTS? And thats a story that even George Soros invested in. Granted VLTS failed trials, and based on what you say, this one has an approved drug.

Honestly, such small cap biotech speculations are like throwing darts in the dark. No amount of reason is good enough to risk buying these. Overall, a good analysis, but the investment is extremely risky.

-- Faisal Laljee